title: Reply to J.S. Abrams et al.
authors.affiliation: Dana Farber-Cancer Institute, Harvard Medical School, Boston, MA david_steensma@dfci.harvard.edu.
authors.forename: David P
authors.initials: DP
authors.lastname: Steensma
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Hagop M
authors.initials: HM
authors.lastname: Kantarjian
mesh_terms: D035843:Biomedical Research; D002986:Clinical Trials as Topic; D004059:Diffusion of Innovation; D017048:Health Care Costs; D006801:Humans; D008495:Medical Oncology; D011787:Quality of Health Care; D012109:Research Support as Topic